Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Experimental Therapeutics & Oncology|February 1, 2011
Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ERNora Zulehner, Margarita Maurer, Józefa Wesierska-GadekJournal of Experimental Therapeutics & Oncology|February 1, 2011
Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cellsDavid Gritsch, Margarita Maurer, Nora Zulehner, et al.Journal of Cellular Physiology|September 14, 2010
Whether to target single or multiple CDKs for therapy? That is the questionJózefa Węsierska-Gądek, Margarita Maurer, Nora Zulehner, et al.Journal of Cellular Biochemistry|February 11, 2011
Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cellsJózefa Węsierska-Gądek, David Gritsch, Nora Zulehner, et al.Journal of Cellular Biochemistry|February 18, 2011
Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cellsJózefa Węsierska-Gądek, David Gritsch, Nora Zulehner, et al.Journal of Cellular Biochemistry|November 17, 2010
Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitorsJózefa Węsierska-Gądek, Stefan Hackl, Nora Zulehner, et al.Journal of Experimental Therapeutics & Oncology|February 1, 2011
Combining an FPTase inhibitor with cisplatin facilitates induction of apoptosis in human A549 lung cancer cellsFranziska Weber, Peter Siska, Matthias Kramer, et al.Biochemical Pharmacology|August 22, 2012
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cellsJózefa Węsierska-Gądek, Nora Zulehner, Franziska Ferk, et al.The Journal of Allergy and Clinical Immunology|February 12, 2015
Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 familyClaudia Kitzmüller, Nora Zulehner, Anargyros Roulias, et al.Plos One|August 16, 2014
The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101Chloé Ackaert, Stefan Kofler, Jutta Horejs-Hoeck, et al.Pageof 1